The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Endologix Announces Favorable Clinical Results for Nellix Technology

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Jan. 31, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm (EVAR)....


Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

GREENWICH, Conn., Jan. 31, 2011 /- Mederi Therapeutics Inc. announced today that it has received FDA 510(k) clearance for its new MDRF1 Generator. The Mederi RF Generator powers the Stretta® System for treatment of Gastroesophageal Reflux Disease (GERD) as well as the Secca®...


Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit

January 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Jan. 31, 2011 /- Attorneys at Lewitt, Hackman, Shapiro, Marshall & Harlan, a southern California law firm, filed a lawsuit regarding a Johnson & Johnson recall of DePuy metal on metal hip replacement devices. The firm filed the suit against DePuy Orthopedics, Inc. and...


Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System

January 31, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Jan. 31, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved its Renegade® HI-FLO™ Fathom® Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic...


Case Western Reserve University presents revolutionary developments in using implantable diamond-coated devices at MEDCon, May 16-18th at Navy Pier in Chicago, IL

January 31, 2011 4:56 am | News | Comments

Medical Electronic Device Conference & Expo (MEDCon) announces that Christian Zorman, Professor of Electrical Engineering & Computer Science at Case Western, will present research findings on studies of implants made from diamonds and flexible polymers at the conference & expo being held in May 2011.

Vanda Pharmaceuticals Files Shelf Registration Statement

January 31, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Jan. 31, 2011 /- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that it has filed a universal shelf registration statement on...


New Monograph Spotlights Urgent Need for Congress to Get Neurotoxins and Other Poisons Out of Vaccines

January 31, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Jan. 31, 2011 /- With the latest round of flu vaccine damage surfacing in mid-January, the FDA is again investigating the association between vaccines and febrile seizures in children. How often do health consumers need the "wool pulled over their eyes" about vaccines? It's...


Boston Scientific Announces FDA Approval of Renegade® HI-FLOâ„¢ Fathom® Pre-Loaded System

January 31, 2011 3:31 am | by Boston Scientific | News | Comments

New system integrates market-leading Renegade HI-FLO Microcatheter with high-torque Fathom-16 Steerable Guidewire for peripheral embolization procedures


Functional Technologies Announces First Quarter 2011 Financial Results

January 31, 2011 2:45 am | by The Associated Press | News | Comments () —Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the first quarter ended November 30, 2010. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with...

Functional Technologies reports lower Q1 loss as operating expenses lower

January 31, 2011 2:45 am | by The Associated Press | News | Comments

Functional Technologies Corp. (TSXV:FEB) tightens first-quarter loss of $773,600 compared to $908,900 a year ago, as operating expenses were lowered to $896,700 in the period.

University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology

January 31, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., Jan. 31, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial (WIN Trial) to treat leukemia...


China Medical Technologies to Announce Results for the Third Fiscal Quarter Ended December 31, 2010 on February 18, 2011

January 31, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the third fiscal quarter...


IBM to Expand U.S. Investment in Entrepreneurs

January 31, 2011 1:32 am | by IBM | News | Comments

IBM today announced that it will invest $150 million in 2011 to fund programs that promote entrepreneurs and new business opportunities in the United States. The announcement was made as part of the White House-led StartUP America campaign launched today. E-mail this page Save to...

Winner Medical Group Inc. to Host First Quarter 2011 Earnings Conference Call on Thursday, February 10, 2011 at 08:30 a.m. EST

January 31, 2011 1:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Jan. 31, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical" or the "Company"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced...


Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics

January 31, 2011 1:31 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Jan. 31, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is pleased to announce...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.